Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Noriaki Nakatani"'
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 6. Recovery of MET protein levels by inhibition of MET/HGF signaling in HCC2108, a lung adenocarcinoma cell line.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4d83f85640286a6465a4fcec6c4bf6
https://doi.org/10.1158/1535-7163.22503195
https://doi.org/10.1158/1535-7163.22503195
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 5. Recovery of MET protein levels by inhibition of MET/HGF signaling.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d50873733389acd2ed1723796a0a3d7
https://doi.org/10.1158/1535-7163.22503198.v1
https://doi.org/10.1158/1535-7163.22503198.v1
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194b33be5bf980de4258d8ecad7c4f16
https://doi.org/10.1158/1535-7163.22503189.v1
https://doi.org/10.1158/1535-7163.22503189.v1
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 7. Comparison of MET protein levels in HGF-autocrine cell lines with those in representative standard cell lines for MET-IHC scoring.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9608ffc63d7b2ee27002ca89146b321d
https://doi.org/10.1158/1535-7163.22503192
https://doi.org/10.1158/1535-7163.22503192
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 4. Representative images of MET-IHC scoring 0, +1, +2, +3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::114477926ee5afc2c2e5b2eec1a191a7
https://doi.org/10.1158/1535-7163.22503201.v1
https://doi.org/10.1158/1535-7163.22503201.v1
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 1. HGF attenuates sensitivity to erlotinib in HCC827 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350bbe81739385ebfd21ba7927b49959
https://doi.org/10.1158/1535-7163.22503210.v1
https://doi.org/10.1158/1535-7163.22503210.v1
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 2. Characteristics of HGF-overexpressing clones in PC-9 and HCC827 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d7892115760a844aa23dd68bf13bef
https://doi.org/10.1158/1535-7163.22503207.v1
https://doi.org/10.1158/1535-7163.22503207.v1
Autor:
Yasushi Yatabe, Eiichi Sasaki, Hiroshi Motegi, Masahiro Aoki, Shigehisa Nagahashi, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Toshihiko Fujii, Kiyoaki Sakata, Yasuko Satoh, Masaichi Abe, Noriaki Nakatani, Eri Hashimoto, Yuji Sano
Supplementary Figure 3. In vivo efficacy of onartuzumab combined with erlotinib in tumors harboring an activating EGFR mutation and with a high level of HGF expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d43ba2f5a00692706329bd616a296cb
https://doi.org/10.1158/1535-7163.22503204
https://doi.org/10.1158/1535-7163.22503204
Autor:
Noriaki Nakatani, Hiroshi Motegi, Yuji Sano, Eiichi Sasaki, Eri Hashimoto, Masaichi Abe, Shigehisa Nagahashi, Masahiro Aoki, Kiyoaki Sakata, Yasuko Satoh, Masamichi Sugimoto, Kaori Fujimoto-Ouchi, Yasushi Yatabe, Toshihiko Fujii
Publikováno v:
Molecular Cancer Therapeutics. 14:533-541
Erlotinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI), benefits survival of patients with non–small cell lung cancer (NSCLC) who harbor activating EGFR mutations. However, elevated expression of hepatocyte growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53daa894b8e278d867c163a3fdaaf528
https://doi.org/10.1158/1535-7163.mct-14-0456
https://doi.org/10.1158/1535-7163.mct-14-0456
Publikováno v:
Journal of the Japan Landslide Society. 48:263-271
2008年5月12日に発生した四川大地震により, 速度が40m/sec以上の高速の岩盤崩壊が多く発生した。日本でも, 雲仙地区で大地震が発生した場合, 溶岩ドームが崩壊して, 岩塊が高速で流下し,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc75aab17fe978a5d740ac1051643333
https://doi.org/10.3313/jls.48.263
https://doi.org/10.3313/jls.48.263